Please find enclosed herewith the Annual Report along with BRSR and AGM Notice for Financial Year 2025-26.

Date: August 21, 2026 Ref:- GHL/2026-27/EXCH/43 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Submission of Annual Report for Financial Year 2025-26. Dear Sir(s), Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Annual Report of the Company, including Business Responsibility and Sustainability Report (BRSR), for the Financial Year 2025-26, along with the Notice of the 22nd Annual General Meeting (AGM), scheduled to be held on Wednesday, September 16, 2026 at 12 Noon (IST), through Video Conferencing (VC)/Other Audio Visual Means (OAVM) in accordance with the relevant circulars issued by the Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI). The said Annual Report and Notice of AGM is also available on the Company's website i.e. https://www.medanta.org/investor-relation Kindly take the above on record. Thanking you, Yours faithfully For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M.No. A17035 Encl: a/a Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 Growing With Purpose, Institutionalising Quality Care. Global Heath Limited Annual Report 2025-26 Medanta - Dedicated to Life Har Ek Jaan Anmol Healthcare institutions are What began as a vision to Clinical expertise, evidence- access to trusted, world-class ultimately defined by the transform healthcare delivery based medicine, established patient-centric care. Each quality of care they deliver in India has evolved into an clinical protocols, advanced new facility brings specialist and the trust they earn from institution committed to medical technologies and doctors, advanced treatment patients and families over time. advancing clinical excellence compassionate care have capabilities and tertiary care Clinical outcomes, medical while keeping compassionate, shaped Medanta's approach services closer to patients and expertise and compassionate patient-centric care at the to patient care over the years. communities that previously care therefore become heart of healing. Over the years, These capabilities support had limited access to such care. inseparable elements of the Medanta has expanded its the management of complex Through this expansion, patient experience and of the capabilities and deepened its and high-acuity conditions Medanta seeks to make institution itself. expertise to manage complex, while maintaining consistency advanced clinical care high-acuity conditions through in clinical outcomes across This belief, embodied in accessible to a wider multidisciplinary collaboration, specialties and locations. Medanta’s guiding principle of population while maintaining advanced medical technologies “Har Ek Jaan Anmol” (Every Life As Medanta expands its the standards of quality, safety and stringent clinical standards. is Invaluable), has shaped the presence into underserved and patient care that define the institution's journey over the markets and regions, the institution. years. objective remains improving About the Report Contents CORPORATE OVERVIEW 04 Bringing World-Class Care OUR INTEGRATED REPORTING JOURNEY REPORTING BOUNDARY AND SCOPE OUR VALUE CREATION CAPITALS Closer to Home FY 2025-26 marks an important milestone in This report covers Medanta’s healthcare operations Medanta’s value creation model is built upon six capitals that 07 Expanding Access to Medanta’s reporting journey with the publication and entities included within the Company’s support its healthcare ecosystem and long-term growth: Specialised Care of its inaugural Integrated Report. Through this consolidated financial statements for the financial 08 Setting New Milestones in report, the Company presents a connected view year ended March 31, 2026. Quality Care of its strategy, governance, performance, risks, 10 Chairman & Managing Director’s Unless otherwise stated, financial and non-financial Financial Capital Manufactured Capital opportunities and future outlook, demonstrating Message information disclosed in this report pertains to how these elements collectively contribute to value 16 Group CEO & Director’s Message operations under Medanta’s management control. Resources available to support Hospitals, medical creation over time. The reporting boundary has been determined operations, investments and infrastructure, diagnostic 22 FY 2025-26 Performance As one of India’s leading multi-specialty healthcare considering operational relevance, availability of growth initiatives. facilities, equipment and 26 Shared Economic Value providers, Medanta operates in an environment information and materiality to stakeholders. operational assets that enable 28 The Medanta Model of Care shaped by evolving patient expectations, delivery of healthcare services. REPORTING PERIOD 30 Large-Format Hospital Model technological advancements, changing disease 34 Patient Experience and Quality patterns and growing healthcare accessibility needs. The report covers the period from April 1, 2025 to The Integrated Report brings together financial and 38 Clinical Outcomes March 31, 2026. non-financial information to provide stakeholders Intellectual Capital Human Capital 46 Network Hospitals with a comprehensive understanding of how the Financial information is presented for the reporting 54 Growth Strategy Company responds to these developments while year, along with comparative information wherever Clinical expertise, research Doctors, nurses, healthcare creating value for patients, employees, investors, relevant to facilitate meaningful assessment of capabilities, digital platforms, professionals and support 58 Beyond Hospitals partners, communities and society. performance and trends. medical innovation, data teams whose expertise and 62 Medanta eICU Initiative systems and organisational commitment drive patient 64 Advanced Medical Technology REPORTING PHILOSOPHY MATERIAL MATTERS knowledge. care excellence. 68 Digital Health Ecosystem The report has been prepared with the objective The content of this report has been informed by 78 Medical Research and Academics of enhancing transparency and demonstrating the Medanta’s materiality assessment process, which 80 Value Creation Model interdependencies between Medanta’s resources, identifies topics that have a significant influence relationships and strategic priorities. It explains on the Company’s ability to create value and are of Social and Relationship Natural Capital 82 Stakeholder Engagement how the Company utilises its capitals to deliver importance to stakeholders. Capital 84 Material Matters high-quality healthcare services, strengthen Environmental resources and clinical outcomes, advance medical innovation and These material matters guide strategic decision- Relationships with patients, initiatives focused on efficient 86 Risk Management generate sustainable value over the short, medium making, risk management, capital allocation and communities, regulators, suppliers, resource utilisation and 90 Environment and long term. sustainability initiatives across the organisation. investors, academic institutions responsible environmental 96 People & Institution Details of the assessment methodology and and other stakeholders. management. The report reflects the principles of integrated material topics are provided in the Materiality 110 Communities and Society thinking and presents information that is material to Assessment section. 116 Governance understanding the Company’s ability to create and FORWARD-LOOKING STATEMENTS 120 Board of Directors and preserve value. BASIS OF PREPARATION Senior Management Certai [Showing first 8,000 characters — download PDF for full document]